Postdoctoral Fellowship in Cancer Biology and Tumor Proteotoxicity at the Institute of Biomedicine of Seville Institute of Biomedicine of Seville in Spain

Postdoctoral opportunity in cancer biology and translational biomedicine at the Institute of Biomedicine of Seville (IBiS) and Universidad de Sevilla.

The group of Cristian Prieto-Garcia, Ramón y Cajal junior group leader, is seeking a highly motivated Marie Curie Postdoctoral Fellow candidate (MSCA-2026) to join a newly established research group in Seville, Spain. The project focuses on innovative cancer therapies based on exploiting tumor proteotoxicity, an emerging therapeutic vulnerability in cancer.

The research environment combines molecular biology, cell signaling, functional genomics, and advanced experimental cancer models, with access to IBiS cutting-edge platforms and a strong network of international collaborators. This is a strong fit for candidates interested in biomedicine, biology, biochemistry, biotechnology, medicine, and related fields, especially those aiming for a career in translational science.

Ideal applicants should have an excellent academic and research record, strong motivation for competitive research, and ambition to develop an international research career. The post highlights direct mentorship from an experienced PI, a dynamic and growing group, and the potential for high-impact publications.

Funding-wise, the opportunity is framed around a Marie Curie Postdoctoral Fellowship, with full support provided for preparing a competitive fellowship application, including project design, CV development, and strategy. The post also mentions the possibility of integration into the University of Seville’s stabilization plan, within which MSCA fellowships are framed.

To apply or express interest, candidates should contact the PI directly by email and discuss the fellowship proposal with the group. No formal deadline is stated in the post.